|
|
Resources
Corporate Results
Divi's Laboratories net down (January 31, 2010)
Glenmark Q3 net up over 15% (January 30, 2010)
Cipla cuts guidance; net profit up 30% (January 29, 2010)
Neuland Lab posts Rs 6.6-cr loss (January 29, 2010)
Suven Life Q3 net profit doubles (January 28, 2010)
Natco Pharma's net up 7% (January 28, 2010)
Zydus Cadila profit zooms on formulation exports (January 26, 2010)
Wockhardt Q4 net profit down 49% (January 26, 2010)
Visa Steel net up 56% (January 25, 2010)
Granules India Q3 net at Rs 6.5 cr (January 23, 2010)
Jubilant Q3 net at Rs 100 cr (January 23, 2010)
Biocon net trebles on higher sales (January 22, 2010)
Dr Reddy's incurs Rs 522-cr loss in Q3 (January 21, 2010)
Novartis net dips 4% in Q3 (January 20, 2010)
Zenotech Labs posts Rs 3 cr (January 14, 2010)
Zenotech net loss widens to Rs 3.41 cr (November 18, 2009)
Anu’s Laboratories net up 6% (November 02, 2009)
Suven Life Q2 net dips 48% to Rs 2.5 cr (November 02, 2009)
Divi’s Labs Q2 net down 37% (November 02, 2009)
Aurobindo Pharma returns to profits with Rs 103-cr net (November 02, 2009)
Orchid posts lower losses in Q2 (November 01, 2009)
Natco Pharma’s net up 12.6% (October 30, 2009)
Vivimed Labs net up at Rs 8 cr Hyderabad, Oct. 28 (October 29, 2009)
Sun Pharma net profit dips 49% (October 29, 2009)
Formulations biz fuels Zydus Cadila net (October 28, 2009)
Emerging markets growth helps Ranbaxy return to black (October 27, 2009)
Granules net doubles to Rs 6 cr (October 27, 2009)
Krebs Bio posts Rs 6 cr loss in Q2 (October 27, 2009)
Lupin Q2 net profit rises 39% (October 27, 2009)
Vimta Labs net down at Rs 67 lakh (October 25, 2009)
Dr Reddy’s Q2 net surges on revenue growth in generics (October 24, 2009)
Jubilant Organosys’ focus on pharma pays (October 23, 2009)
Biocon Q2 net grows 86%, income 16% (October 23, 2009)
Domestic growth aids Piramal Health (October 23, 2009)
Celestial Lab posts flat net (August 04, 2009)
Strides posts Rs 60-cr net in Q2 (August 01, 2009)
Orchid Chem lowers loss in Q1 (August 01, 2009)
Aurobindo Q1 net trebles (August 01, 2009)
Wockhardt posts Rs 190-cr loss (July 31, 2009)
Matrix Labs net down 49% (July 31, 2009)
Natco Pharma profit up 5% (July 31, 2009)
Lupin net up 65% at Rs 180 cr (July 30, 2009)
Sun Pharma profits down 57% to Rs 122 cr (July 30, 2009)
Suven Life Sciences Q1 net up 36% (July 30, 2009)
GSK Pharma sales rise (July 29, 2009)
Glenmark net profit dips 91% on forex loss (July 28, 2009)
Granules India net doubles (July 28, 2009)
Vimta Lab’s net down 26 pc (July 28, 2009)
SMS Pharma profits down (July 28, 2009)
Ranbaxy moves back into the black (July 25, 2009)
Biocon net up 58% in Q1 on services push (July 24, 2009)
Custom manufacturing under pressure: Piramal (July 23, 2009)
Dr Reddy’s Q1 net more than doubles (July 22, 2009)
Jubilant’s Q1 profit rises to Rs 145 cr (July 16, 2009)
Vivimed Lab’s yearly net up 5% (July 03, 2009)
Natco Q4 net falls marginally (July 02, 2009)
Anu’s Labs Q4 net down (July 01, 2009)
Orchid in red over forex, derivatives losses (June 30, 2009)
Matrix posts Rs 189 cr profit (June 27, 2009)
Divis Labs Q4 net up 13% (June 08, 2009)
Sun Pharma fourth-quarter net falls 45% to Rs 394 cr (May 31, 2009)
Unichem Q4 net rises 50% (May 28, 2009)
Gayatri Bioorganics posts loss in Q4 (May 27, 2009)
Neuland net up at Rs 8 cr in Q4 (May 23, 2009)
Impairment loss offsets revenue growth for Dr Reddy’s (May 20, 2009)
Dr Reddy’s takes Betapharm hit (May 19, 2009)
Torrent Pharma Q4 net down 18% (May 16, 2009)
Lupin net rises 64% in Q4 on all-round growth (May 14, 2009)
Alembic sales rise 11%, net down 90% (May 10, 2009)
Novartis Q4 net down 4% (May 09, 2009)
Avon Organics records profit in Q4 (May 05, 2009)
Godavari Drugs profit at Rs 11 lakh (May 03, 2009)
SMS Pharma posts Rs 8.69 cr loss (May 03, 2009)
Aurobindo Pharma Q4 net up 18.7% (May 02, 2009)
Suven Life Q4 net down 82% (May 01, 2009)
Vimta Labs Q4 net up 23% (April 29, 2009)
Biocon Q4 net down 61% on mark-to-market losses (April 29, 2009)
GSK Pharma Q1 net up 18% (April 29, 2009)
Strides posts Rs 22-cr standalone profit in Q1 (April 27, 2009)
Wockhardt posts full-year net loss of Rs 139 cr (April 26, 2009)
Cipla Q4 net profit up on better product-mix (April 25, 2009)
Forex losses dent Piramal Healthcare’s FY09 net (April 25, 2009)
Ranbaxy posts Rs 777-cr loss in first quarter (April 25, 2009)
GSK Pharma to increase field-force (February 19, 2009)
Anu's Labs net down (February 03, 2009)
Granules India’s Q2 net down (February 03, 2009)
Jupiter Bioscience Q3 net slips 4 pc (February 03, 2009)
Fresenius Kabi suffers Rs 63-cr loss in Q3 (February 01, 2009)
Sun Pharma initiates mediation on Taro (February 01, 2009)
Orchid Chem posts loss (January 30, 2009)
Lupin net down 35% (January 30, 2009)
Natco Pharma net up 6% (January 29, 2009)
Zydus Cadila consolidated net up 17% (January 29, 2009)
Glenmark consolidated net down 71% (January 28, 2009)
Divis Labs net, revenue down (January 25, 2009)
Piramal Healthcare Q3 net down on forex loss (January 23, 2009)
Hikal net rises 8% on higher sales (January 23, 2009)
Novartis net up 7% (January 23, 2009)
Ranbaxy reports net loss of Rs 806 cr (January 23, 2009)
Neuland Lab net down 54% (January 23, 2009)
Cipla Q3 net up; sales post growth (January 23, 2009)
Biocon standalone Q3 net profit dips 91% (January 22, 2009)
Suven Life Q2 net slips 86% (January 21, 2009)
Dr Reddy’s posts Rs 192-cr net in Q3 (January 21, 2009)
Vimta Labs posts Rs 1.28 cr loss (January 19, 2009)
Year : 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002
|
|
RSS Feeds